Taiwan’s ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
KAOHSIUNG, April 14, 2025 /PRNewswire/ -- Taiwan – ACRO Biomedical Co., Ltd. (TWSE: 6748) announced today that its ABCcolla® Collagen Ophthalmic Matrix has received regulatory approval from Taiwan's Ministry of